
Advances in Drug Discovery & Development 2024
This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.
This online symposium will explore:
- Leveraging AI for transformative drug discovery and development
- Engineering molecular therapeutics from discovery through translation
- Accelerating precision medicine through disease modeling and precision dosing
- Machine learning and simulations to accelerate clinical trials
- Small molecule drug discovery and development
Speakers

Kevin McCann
High Throughput Mass Spec Manager
Agilent Technologies

Matthew Arnold
Principal Analyst, Clarivate plc

Sharmeen Roy, PharmD
Chief Science and Strategy Officer
DoseMe

Kevin Grady
Senior Market Development Manager
Lonza

Michael Kiebish, PhD
Chief Precision Medicine Officer
BPGbio

Aurita Menezes, PhD
Senior Market Development Manager
Lonza

Melanie Homberg, PhD
Market Development Manager
Lonza

Steve Murphy, PhD
Workflows and Applications Manager
Agilent Technologies

Hong Wan, PhD
President and CEO
Tallac Therapeutics

Platinum Sponsor

Technology Spotlight Sponsor




Standard Sponsor





Now Available on Demand!
Experiencing issues viewing the form? Click here to access an alternate version